FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/068176 [Registered on: 31/05/2024] Trial Registered Prospectively
Last Modified On: 28/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Expression of various cancer markers in thyroid cancer 
Scientific Title of Study   Immunohistochemical expression of CK19 and CD56 in thyroid neoplasms 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Tanu Priya  
Designation  PG student 
Affiliation  BPS Govt Medical College for women Khanpur Kalan Sonipat 
Address  Department of Pathology, BPS GMC (W), Khanpur kalan, Sonipat, Haryana

Sonipat
HARYANA
131305
India 
Phone  8569856332  
Fax    
Email  tanupriyasheoran@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Monika Gathwal 
Designation  Professor 
Affiliation  BPS Govt Medical College for women Khanpur Kalan Sonipat 
Address  Department of Pathology, BPS GMC (W), Khanpur kalan, Sonipat, Haryana

Sonipat
HARYANA
131305
India 
Phone  8569856332  
Fax    
Email  drmonikabgathwal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Tanu Priya  
Designation  PG student 
Affiliation  BPS Govt Medical College for women Khanpur Kalan Sonipat 
Address  Department of Pathology, BPS GMC (W), Khanpur kalan, Sonipat, Haryana


HARYANA
131305
India 
Phone  8569856332  
Fax    
Email  tanupriyasheoran@gmail.com  
 
Source of Monetary or Material Support  
Bhagat phool singh government medical college for women 
 
Primary Sponsor  
Name  Tanu Priya 
Address  Department of Pathology, BPS GMC (W), Khanpur kalan, Sonipat, Haryana, India, 131305. 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tanu Priya  Dept of Pathology  Room no 5, BPS GMC, Khanpur kalan, Sonipat, Haryana
Sonipat
HARYANA 
08569856332

tanupriyasheoran@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C73||Malignant neoplasm of thyroid gland,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  nil  nil 
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  All proven cases of thyroid neoplasm 
 
ExclusionCriteria 
Details  non neoplastic lesions of thyroid
blocks could not be retrieved
cases who had undergone chemotherapy and radiotherapy 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
CD56 and CK19  baseline  
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="53"
Sample Size from India="53" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Title of my study is immunohistochemical expression of CK19 and CD56 in thyroid neoplasms whose objectives are to classify thyroid neoplasms on the basis of histomorphological features, to estimate the expression of IHC marker CK19 in thyroid neoplasms, to estimate the expression of IHC marker CD56 in thyroid neoplasms, to correlate the expression of CK19 and CD56 in thyroid neoplasms. Sample size is 53. All proven cases of thyroid neoplasms are included. 
Close